{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:16:11Z","timestamp":1722888971526},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T00:00:00Z","timestamp":1204588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00280-008-0693-y","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T11:59:08Z","timestamp":1204545548000},"page":"1103-1109","source":"Crossref","is-referenced-by-count":17,"title":["A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"Akihiro","family":"Nakajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Hokita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiya","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futoshi","family":"Miyazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaaki","family":"Etoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hamanoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeho","family":"Maenohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoharu","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Aridome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Natsugoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Takiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyuji","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Aikou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Kyushu Taxol, TS-1, Study Group (KTT-SG)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,4]]},"reference":[{"key":"693_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thum MJ, American Cancer Society (2004) Cancer statistics. CA Cancer J Clin 54:8\u201329","journal-title":"CA Cancer J Clin"},{"key":"693_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M","volume":"83","author":"P Pisani","year":"1999","unstructured":"Pisani P, Parkin DM, Bray F, Ferlay J (1999) Erratum: estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18\u201329","journal-title":"Int J Cancer"},{"key":"693_CR3","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/sj.bjc.6601413","volume":"89","author":"W Koizumi","year":"2003","unstructured":"Koizumi W, Tanabe S, Saigenji K, Ohtsu A, Boku N, Nagashima F, Shirao K, Matsumura Y, Gotoh M (2003) Phase I\/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89:2207\u201312","journal-title":"Br J Cancer"},{"key":"693_CR4","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1158\/1078-0432.CCR-05-2425","volume":"12","author":"K Yoshida","year":"2006","unstructured":"Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M, Sakamoto J, Nishiyama M (2006) Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clin Cancer Res 12:3402\u20137","journal-title":"Clin Cancer Res"},{"key":"693_CR5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.bjc.6603072","volume":"94","author":"M Inokuchi","year":"2006","unstructured":"Inokuchi M, Yamashita T, Yamada H, Kojima K, Ichikawa W, Nihei Z, Kawano T, Sugihara K (2006) Phase I\/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer. Br J Cancer 94:1130\u20135","journal-title":"Br J Cancer"},{"key":"693_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P","volume":"72","author":"AM Murad","year":"1993","unstructured":"Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M (1993) Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72:37\u201341","journal-title":"Cancer"},{"key":"693_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bjc.1995.114","volume":"71","author":"S Pyrhonen","year":"1995","unstructured":"Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M (1995) Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587\u201391","journal-title":"Br J Cancer"},{"key":"693_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1008243606668","volume":"8","author":"B Glimelius","year":"1997","unstructured":"Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, Svensson C, Enander LK, Linne T, Sellstrom H, Heuman R (1997) Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8:163\u20138","journal-title":"Ann Oncol"},{"key":"693_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002800050561","volume":"39","author":"T Takechi","year":"1997","unstructured":"Takechi T, Nakano K, Uchida J, Mita A, Toko K, Takeda S, Unemi N, Shirasaka T (1997) Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats. Cancer Chemother Pharmacol 39:205\u201311","journal-title":"Cancer Chemother Pharmacol"},{"key":"693_CR10","first-page":"693","volume":"13","author":"M Fukushima","year":"1998","unstructured":"Fukushima M, Satake H, Uchida J, Shimamoto Y, Kato T, Takechi T, Okabe H, Fujioka A, Nakano K, Ohshimo H, Takeda S, Shirasaka T (1998) Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts. Int J Oncol 13:693\u20138","journal-title":"Int J Oncol"},{"key":"693_CR11","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/S0959-8049(03)00513-6","volume":"39","author":"H Fujiwara","year":"2003","unstructured":"Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Nakaya T, Yonezawa H, Oyama K, Takahashi M, Saito K, Takechi T, Fukushima M, Shirasaka T (2003) Superior antitumor activity of S-1 in tumors with a high dihydropyrimidine dehydrogenase activity. Eur J Cancer 39:2387\u201394","journal-title":"Eur J Cancer"},{"key":"693_CR12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0959-8049(98)00211-1","volume":"34","author":"Y Sakata","year":"2005","unstructured":"Sakata Y, Ohtsu A, Horikoshi N (2005) Late phase II study of novel oral fluoropyrimidine anti cancer drug S-1 in advanced and recurrent gastrointestinal cancer. Eur J Cancer 34:1715\u20131720","journal-title":"Eur J Cancer"},{"key":"693_CR13","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1021\/bi00514a041","volume":"20","author":"PB Schiff","year":"1981","unstructured":"Schiff PB, Horwitz SB (1981) Taxol assembles tubulin in the absence of exogenous guanosine 5\u2032-triphosphate or microtubule-associated proteins. Biochemistry 20:3247\u201352","journal-title":"Biochemistry"},{"issue":"9","key":"693_CR14","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1073\/pnas.78.9.5608","volume":"78","author":"M Brabander De","year":"1981","unstructured":"De Brabander M, Geuens G, Nuydens R, Willebrords R, De Mey J (1981) Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc Natl Acad Sci USA 78(9):5608\u2013612","journal-title":"Proc Natl Acad Sci USA"},{"key":"693_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s101200200015","volume":"5","author":"K Yamaguchi","year":"2002","unstructured":"Yamaguchi K, Tada M, Horikoshi N, Otani T, Takiuchi H, Saitoh S, Kanamaru R, Kasai Y, Koizumi W, Sakata Y, Taguchi T, Paclitaxel Gastric Cancer Study Group in Japan (2002) Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer. Gastric Cancer 5:90\u20135","journal-title":"Gastric Cancer"},{"key":"693_CR16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00280-005-0122-4","volume":"57","author":"S Hokita","year":"2006","unstructured":"Hokita S, Aikou T, Miyazono F, Ishigami S, Aridome K, Maenohara S, Saihara T, Suenaga K, Nomura H, Maeda S, Takatori H, Arima H, Uchikado Y, Natsugoe S, Takao S (2006) A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer. Cancer Chemother Pharmacol 57:736\u201340","journal-title":"Cancer Chemother Pharmacol"},{"key":"693_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Natl Cancer Inst 92:205\u201316","journal-title":"Natl Cancer Inst"},{"key":"693_CR18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/sj.bjc.6603497","volume":"95","author":"E Mochiki","year":"2006","unstructured":"Mochiki E, Ohno T, Kamiyama Y, Aihara R, Haga N, Ojima H, Nakamura J, Ohsawa H, Nakabayashi T, Takeuchi K, Asao T, Kuwano H, North Kanto Gastric Cancer Study Group (2006) Phase I\/II study of S-1 combined with paclitaxel in patients with unresectable and\/or recurrent advanced gastric cancer. Br J Cancer 95:1642\u20137","journal-title":"Br J Cancer"},{"key":"693_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10120-006-0394-3","volume":"10","author":"A Nakajo","year":"2007","unstructured":"Nakajo A, Natsugoe S, Hokita S, Ishigami S, Takatori H, Arigami T, Uenosono Y, Aridome K, Aikou T (2007) Successful treatment of advanced gastric cancer by surgical resection following combination chemotherapy with oral S-1 and biweekly paclitaxel. Gastric Cancer 10:58\u201362","journal-title":"Gastric Cancer"},{"key":"693_CR20","first-page":"19","volume":"32","author":"H Takiuchi","year":"2005","unstructured":"Takiuchi H, Goto M, Kawabe S, Ohta S, Katsu K (2005) Second-line chemotherapy in gastric cancer. Jpn J Cancer Chemo 32:19\u201323","journal-title":"Jpn J Cancer Chemo"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-008-0693-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-008-0693-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-008-0693-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:06:51Z","timestamp":1559038011000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-008-0693-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,4]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1007\/s00280-008-0693-y","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2008,3,4]]}}}